10 things you should know about Article 22 EUMR
What does the EU Commission’s change of policy mean in practice for companies around the world and their M&A practice?
On 26 March 2021, the EU Commission (“EC”) has announced a change of policy with regards to the application of Article 22 of the EU Merger Regulation (“EUMR”) and acquisitions, notably in the TMT and Healthcare and Life Sciences sectors, that don’t meet the EU nor the national thresholds, can now be reviewed by the EC following referral requests from Member states.
The notes below cover why the EC’s change of policy is of interest for M&A transactions in the TMT and HLS sectors respectively and the top 10 things companies around the world need to know when running M&A transactions.
.jpg?crop=300,495&format=webply&auto=webp)
.jpg?crop=300,495&format=webply&auto=webp)
.jpg?crop=300,495&format=webply&auto=webp)
